AJP - Endocrinology and Metabolism, Vol 247, Issue 3 380-E384, Copyright © 1984 by American Physiological Society

ARTICLES

The human sympathochromaffin system

S. D. Shah, T. F. Tse, W. E. Clutter and P. E. Cryer

Hypoglycemia stimulates adrenomedullary epinephrine secretion; standing stimulates sympathetic neural norepinephrine release. In five bilaterally adrenalectomized persons plasma epinephrine, measured with a sensitive single-isotope derivative assay, rose from 15 +/- 2 to 35 +/- 7 pg/ml (P less than 0.02) during hypoglycemia but did not increase during standing. In contrast, plasma norepinephrine rose during standing but not during hypoglycemia. Thus, in humans 1) extra-adrenal epinephrine secretion is regulated and derived from innervated cells other than sympathetic postganglionic neurons; 2) because the plasma levels of epinephrine in adrenalectomized individuals even in response to the potent stimulus of hypoglycemia are below physiological thresholds, any biological actions of extra-adrenal epinephrine in adults must be paracrine rather than endocrine in nature; 3) hypoglycemia does not appear to stimulate the sympathetic nervous system. In view of these findings, we propose that extra-CNS catecholamine-producing tissues be termed the sympathochromaffin system consisting of two components: 1) the sympathetic nervous system that releases the neurotransmitter norepinephrine from its postganglionic neurons, and 2) the chromaffin tissues, including the adrenal medullae, that contain cells that secrete epinephrine, norepinephrine, or dopamine. The plasma epinephrine concentration is a valid measure of its chromaffin tissue (predominantly adrenomedullary) secretion, whereas the plasma norepinephrine concentration is an index of sympathetic neuronal activity under some but not all conditions.

This article has been cited by other articles:

				M. A. DeRosa and P. E. Cryer Hypoglycemia and the sympathoadrenal system: neurogenic symptoms are largely the result of sympathetic neural, rather than adrenomedullary, activation Am J Physiol Endocrinol Metab, July 1, 2004; 287(1): E32 - E41. [Abstract] [Full Text] [PDF]

				W. I. Sivitz, J. A. Herlein, D. A. Morgan, B. D. Fink, B. G. Phillips, and W. G. Haynes Effect of Acute and Antecedent Hypoglycemia on Sympathetic Neural Activity and Catecholamine Responsiveness in Normal Rats Diabetes, May 1, 2001; 50(5): 1119 - 1125. [Abstract] [Full Text]

				M. Mannelli, L. Ianni, C. Lazzeri, W. Castellani, C. Pupilli, G. La Villa, G. Barletta, M. Serio, and F. Franchi In Vivo Evidence That Endogenous Dopamine Modulates Sympathetic Activity in Man Hypertension, September 1, 1999; 34(3): 398 - 402. [Abstract] [Full Text] [PDF]

				J. S. Greiwe, R. C. Hickner, S. D. Shah, P. E. Cryer, and J. O. Holloszy Norepinephrine response to exercise at the same relative intensity before and after endurance exercise training J Appl Physiol, February 1, 1999; 86(2): 531 - 535. [Abstract] [Full Text] [PDF]

				D. S. Paramore, C. G. Fanelli, S. D. Shah, and P. E. Cryer Forearm norepinephrine spillover during standing, hyperinsulinemia, and hypoglycemia Am J Physiol Endocrinol Metab, November 1, 1998; 275(5): E872 - E881. [Abstract] [Full Text] [PDF]